The U.S. Veterans Affairs Department has awarded pharmaceutical distributor and health information technology company McKesson Corp. a two-year contract worth about $8 billion to supply pharmaceuticals to all of the VA's medical centers, outpatient clinics and consolidated mail outpatient pharmacies. According to the VA and McKesson, the two-year base contract includes options for up to three two-year extensions. The award has a total estimated value of about $32 billion, or about $4 billion per year, according to the VA. The agreement will allow San Francisco-based McKesson to continue supplying pharmaceuticals at more than 700 locations, including more than 270 medical centers. “Over the past eight years, McKesson has partnered with the VA to serve the healthcare needs of America's veterans,” Paul Julian, executive vice president and group president of McKesson, said in a news release.
Late News: VA awards McKesson 2-year contract for pharmaceuticals
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.